Logo image of ALEXP.PA

ONE EXPERIENCE (ALEXP.PA) Stock Fundamental Analysis

EPA:ALEXP - Euronext Paris - Matif - FR0013266772 - Common Stock - Currency: EUR

1.61  -0.01 (-0.62%)

Fundamental Rating

2

ALEXP gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 58 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of ALEXP have multiple concerns. ALEXP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALEXP had negative earnings in the past year.
ALEXP had a positive operating cash flow in the past year.
ALEXP.PA Yearly Net Income VS EBIT VS OCF VS FCFALEXP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 200K -200K 400K -400K -600K -800K

1.2 Ratios

The Return On Assets of ALEXP (-8.82%) is worse than 65.52% of its industry peers.
With a Return On Equity value of -15.81%, ALEXP perfoms like the industry average, outperforming 46.55% of the companies in the same industry.
Industry RankSector Rank
ROA -8.82%
ROE -15.81%
ROIC N/A
ROA(3y)-3.71%
ROA(5y)N/A
ROE(3y)-7.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALEXP.PA Yearly ROA, ROE, ROICALEXP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -2 -4 -6 -8

1.3 Margins

With a Gross Margin value of 39.77%, ALEXP perfoms like the industry average, outperforming 46.55% of the companies in the same industry.
ALEXP's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALEXP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.49%
GM growth 5YN/A
ALEXP.PA Yearly Profit, Operating, Gross MarginsALEXP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 -20 40 -40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

ALEXP does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALEXP has more shares outstanding than it did 1 year ago.
ALEXP has a better debt/assets ratio than last year.
ALEXP.PA Yearly Shares OutstandingALEXP.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M
ALEXP.PA Yearly Total Debt VS Total AssetsALEXP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of 1.47, we must say that ALEXP is in the distress zone and has some risk of bankruptcy.
ALEXP has a Altman-Z score of 1.47. This is comparable to the rest of the industry: ALEXP outperforms 53.45% of its industry peers.
ALEXP has a debt to FCF ratio of 5.47. This is a neutral value as ALEXP would need 5.47 years to pay back of all of its debts.
The Debt to FCF ratio of ALEXP (5.47) is better than 70.69% of its industry peers.
A Debt/Equity ratio of 0.27 indicates that ALEXP is not too dependend on debt financing.
ALEXP has a Debt to Equity ratio of 0.27. This is in the better half of the industry: ALEXP outperforms 79.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 5.47
Altman-Z 1.47
ROIC/WACCN/A
WACC7.02%
ALEXP.PA Yearly LT Debt VS Equity VS FCFALEXP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M 4M 6M 8M

2.3 Liquidity

ALEXP has a Current Ratio of 0.95. This is a bad value and indicates that ALEXP is not financially healthy enough and could expect problems in meeting its short term obligations.
ALEXP has a Current ratio (0.95) which is in line with its industry peers.
ALEXP has a Quick Ratio of 0.95. This is a bad value and indicates that ALEXP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ALEXP (0.95) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.95
ALEXP.PA Yearly Current Assets VS Current LiabilitesALEXP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1M 2M 3M 4M

More info and screens

3

3. Growth

3.1 Past

ALEXP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -76.86%.
ALEXP shows a strong growth in Revenue. In the last year, the Revenue has grown by 84.09%.
Measured over the past years, ALEXP shows a very strong growth in Revenue. The Revenue has been growing by 91.23% on average per year.
EPS 1Y (TTM)-76.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103%
Revenue 1Y (TTM)84.09%
Revenue growth 3Y91.23%
Revenue growth 5YN/A
Sales Q2Q%67.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALEXP.PA Yearly Revenue VS EstimatesALEXP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALEXP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALEXP.PA Price Earnings VS Forward Price EarningsALEXP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ALEXP is valued a bit more expensive than the industry average as 63.79% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 43.07
EV/EBITDA N/A
ALEXP.PA Per share dataALEXP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALEXP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ONE EXPERIENCE

EPA:ALEXP (7/15/2025, 7:00:00 PM)

1.61

-0.01 (-0.62%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners13.57%
Inst Owner ChangeN/A
Ins Owners37.9%
Ins Owner ChangeN/A
Market Cap14.99M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.47
P/FCF 43.07
P/OCF 28.55
P/B 2.09
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.04
FCFY2.32%
OCF(TTM)0.06
OCFY3.5%
SpS0.65
BVpS0.77
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.82%
ROE -15.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.77%
FCFM 5.73%
ROA(3y)-3.71%
ROA(5y)N/A
ROE(3y)-7.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.49%
GM growth 5YN/A
F-Score5
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 5.47
Debt/EBITDA N/A
Cap/Depr 63.21%
Cap/Sales 2.91%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.95
Altman-Z 1.47
F-Score5
WACC7.02%
ROIC/WACCN/A
Cap/Depr(3y)180.68%
Cap/Depr(5y)N/A
Cap/Sales(3y)18.68%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)84.09%
Revenue growth 3Y91.23%
Revenue growth 5YN/A
Sales Q2Q%67.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3727.27%
OCF growth 3YN/A
OCF growth 5YN/A